These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Clinical significance of the leukocyte migration inhibition reaction to HBsAg in viral hepatitis B in children]. Cherednichenko TV; Tamarova LD Vopr Okhr Materin Det; 1980 Sep; 25(9):8-12. PubMed ID: 7423898 [No Abstract] [Full Text] [Related]
5. Delayed type hypersensitivity (DTH) skin reaction to hepatitis B surface antigen (HBsAg) in patients with type B acute and chronic hepatitis. Nagafuchi S; Kashiwagi S; Hayashi S; Inoue T; Imayama S; Takeshita M; Kikuchi M Clin Exp Immunol; 1985 Sep; 61(3):569-76. PubMed ID: 4075587 [TBL] [Abstract][Full Text] [Related]
6. Delayed-type hypersensitivity skin reaction to HBsAg and immunohistopathologic study of liver in patients with acute type B viral hepatitis. Nagafuchi S; Kashiwagi S; Tsuji Y; Miyata Y; Iwakiri R; Takeshita M; Niho Y; Kikuchi M Microbiol Immunol; 1989; 33(7):539-48. PubMed ID: 2770563 [TBL] [Abstract][Full Text] [Related]
7. Delayed hypersensitivity and Arthus reaction to purified hepatitis B surface antigen (HBsAg) in immunized chimpanzees. Trepo C; Vnek J; Prince AM Clin Immunol Immunopathol; 1975 Nov; 4(4):528-37. PubMed ID: 128431 [No Abstract] [Full Text] [Related]
8. Cell-mediated immune reactivity to hepatitis B surface antigen in liver diseases. de Moura MC; Vernace SJ; Paronetto F Gastroenterology; 1975 Aug; 69(2):310-17. PubMed ID: 1080122 [TBL] [Abstract][Full Text] [Related]
9. [Radioimmunological study of the antigen and antibody dynamics of viral hepatitis A and B patients]. Reĭnaru IK; Belokon VN; Pavlovskiĭ GV Zh Mikrobiol Epidemiol Immunobiol; 1983 Apr; (4):58-61. PubMed ID: 6306963 [TBL] [Abstract][Full Text] [Related]
10. [Leukocyte migration inhibition test in patients with viral hepatitis and chronic active hepatitis]. Ubysz-Jerzmanowska K; Jerzmanowski A; Słowińska I; Szkudlińska B; Gierłowska E; Stempień R Pol Tyg Lek; 1978 Sep; 33(38):1493-6. PubMed ID: 693398 [No Abstract] [Full Text] [Related]
11. Organ-specificity and diagnostic value of cell-mediated immunity against a liver-specific membrane protein: studies in hepatic and non-hepatic diseases. Meyer zum Büschenfelde KH; Alberti A; Arnold W; Freudenberg J Klin Wochenschr; 1975 Nov; 53(22):1061-7. PubMed ID: 1083922 [TBL] [Abstract][Full Text] [Related]
12. Lack of leukocyte migration inhibition by hepatitis B antigen and normal nonspecific immunoreactivity in asymptomatic carriers. Desaules M; Frei PC; Libanska J; Wuilleret B J Infect Dis; 1976 Nov; 134(5):505-9. PubMed ID: 993619 [TBL] [Abstract][Full Text] [Related]
14. Lymphocyte transformation and leucocyte migration-inhibition by Australia antigen. Laiwah AA; Chaudhuri AK; Anderson JR Clin Exp Immunol; 1973 Sep; 15(1):27-34. PubMed ID: 4765719 [TBL] [Abstract][Full Text] [Related]
15. A delayed type hypersensitivity (DTH) skin reaction to hepatitis B surface antigen (HBsAg) and intradermal hepatitis B vaccination. Nagafuchi S; Kashiwagi S; Hayashi J; Katsuta H; Ikematsu H; Harada M Fukuoka Igaku Zasshi; 2004 Dec; 95(12):305-13. PubMed ID: 15732372 [TBL] [Abstract][Full Text] [Related]
16. [Markers of the hepatitis B virus in the blood serum and liver tissue in chronic diffuse diseases]. Mansurov KhKh; Mirodzhov GK; Tkalicheva LI; Asfandiiarova NS Arkh Patol; 1989; 51(8):40-5. PubMed ID: 2818226 [TBL] [Abstract][Full Text] [Related]
17. Lack of leukocyte migration inhibition by hepatitis B surface antigen in hepatocellular carcinoma patients. Lee CS; Chang KJ; Chen DS; Lin TY Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1979 Sep; 12(3):86-92. PubMed ID: 94850 [TBL] [Abstract][Full Text] [Related]
18. [Studies of an assay system for dialyzable leukocyte extracts (DLE)--influence of DLE on leukocyte migration inhibition test by HBsAg]. Hashimoto Y; Sekiguchi S Hokkaido Igaku Zasshi; 1985 Sep; 60(5):763-8. PubMed ID: 3908264 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of liver cell damage in acute hepatitis B. Mohite BJ; Rath S; Bal V; Kamat SA; Marathe SN; Zuckerman AJ; Kamat RS J Med Virol; 1987 Jul; 22(3):199-210. PubMed ID: 3498006 [TBL] [Abstract][Full Text] [Related]
20. Influence of (+)-cyanidanol-3 on the leukocyte migration inhibition test carried out in the presence of purified protein derivative and hepatitis B surface antigen. Vallotton JJ; Frei PC Infect Immun; 1981 May; 32(2):432-7. PubMed ID: 7251131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]